DEPO-PROVERA

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: b42b7533e3c3160b
Drug Approval Canada Name: DEPO-PROVERA
Product Name: DEPO-PROVERA
Status: Marketed
Status Date: 2022-04-25
Original Market Date: 2022-04-25
Din: 02523493
Drug Class: Human
Dosage Form: Suspension
Route Of Administration: Intramuscular
Schedule: Prescription
Ahfs: 68:12.00
Atc Original: G03AC06 MEDROXYPROGESTERONE
Atc Name: g 03 ac 06
Aig Number: 0106339003
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

MEDROXYPROGESTERONE ACETATE

150 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b42b7533e3c3160b

Type

Standard